Fucose clinical trials
How each study uses Fucose is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Keep track of what changes. Save the Fucose studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesApprovals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2012 (1)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2026 | 1 |
Who runs them
Industry 3 · Other 1
AUG Therapeutics (2) · Orpha Labs (1) · Oregon Health and Science University (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 3, 2 in phase 3
Studies that test Fucose, phase 3 first.
- Nov 2026A Study to Evaluate Efficacy and Safety of AVTX-803 in Patients With Leukocyte Adhesion Deficiency Type IIPhase 3 · AUG Therapeutics
- Dec 2026An Extension Study Assessing the Safety and Efficacy of AVTX-803 in Subjects With Leukocyte Adhesion Deficiency Type IIPhase 3 · AUG Therapeutics
- Jul 2027A Phase II Study With Exploratory Outcomes of Fucose Supplementation in GLUT1 Deficiency SyndromePhase 2 · Oregon Health and Science University
Studies
Open first, then newest update. How each study uses Fucose is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- A Phase II Study With Exploratory Outcomes of Fucose Supplementation in GLUT1 Deficiency SyndromeRecruitingPhase 2Oregon Health and Science UniversityNCT07432490Written as L-fucose
- An Extension Study Assessing the Safety and Efficacy of AVTX-803 in Subjects With Leukocyte Adhesion Deficiency Type IIRecruitingPhase 3AUG TherapeuticsNCT05754450Written as AVTX-803
- A Study to Evaluate Efficacy and Safety of AVTX-803 in Patients With Leukocyte Adhesion Deficiency Type IIRecruitingPhase 3AUG TherapeuticsNCT05462587Written as AVTX-803 (L-Fucose)
- Study of ORL-1F (L-fucose) in Patients With Leukocyte Adhesion Deficiency Type IICompletedPhase 1/2Orpha LabsNCT03354533Written as L-fucose
Codes
What other systems call Fucose · ClinicalTrials.gg INT007528
- MeSH (NLM) D005643FucoseConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 28RYY2IV3FELFUCOSEConfirmed FDA, NLM, Wikidata
- RxNorm 2466731One source FDA
- Wikidata Q105212067aldehydo-L-fucoseConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C68481FucoseOne source FDA
- DrugBank DB15236One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D005643 | Fucose | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 28RYY2IV3F | ELFUCOSE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2466731 | — | One source FDA |
| Wikidata | Q105212067 | aldehydo-L-fucose | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C68481 | Fucose | One source FDA |
| DrugBank | DB15236 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.